Is the addition of Bevacizumab to ovarian cancer treatment chemotherapy a settled question?
Not every nail needs a hammer
Need to Know...
How to deliver Cancer Care in rural areas?
We need to improve compliance with Breast Cancer Hormonal Therapy
How to improve compliance with Breast Cancer Hormonal Therapy?
Joan had been taking a pill to reduce her risk for a recurrence of her Breast Cancer for the last 3 years. She had gotten through the initial phase of side effects with some difficulty, but the hot flashes had diminished, and she had avoided weight gain with greater attention to her diet and exercise habits. She now called the office with complaints of new onset of nausea and insisted it was her medication, and she wanted to discontinue it.
Does my blood clot mean that I have Cancer?
When a patient develops a blood clot in the Deep Venous system or in the blood vessels of the lung, the clot needs to be thinned out with blood thinners so that it doesn’t grow, break off and migrate. The patient also needs to be evaluated whether there was a cause for the blood clot. The pathways of management and length of anticoagulation or “blood thinning” are different for Provoked or Unprovoked Clots.
Breast Cancer Screening
A few years ago, I was visiting an old friend, a Medical School classmate, who lives in the UK. We had turned 50, and per the National Health Service guidelines, she was eligible to register for a 3 yearly screening mammogram. She had seen several friends go through this process, and be found to have DCIS (a non invasive precursor of the real culprit), and go through lumpectomy, radiation and hormonal intervention. The discussion of the reasonable management of DCIS is a topic for another day. She was reluctant to get sucked into the vortex, and was seriously considering not registering for her screenings. This led to a discussion of the real value of screening mammograms. I was reminded of that discussion as I read the update on the screening recommendations in the NEJM of June 11, 2015.
Should John be screened for Prostate Cancer?
John came in for his regular annual check up. He is 75 years old, is on medications for his heart disease, has COPD, and was hospitalized twice last winter for pneumonia. He had to go to a rehabilitation center to get better. He had blood work for this visit, to check his kidneys, his cholesterol and his liver tests. Should he have a PSA to screen for Prostate Cancer?
What are generic drugs and Bio-similars?
What are generic drugs and biosimilars?
My patient has been on a pill to treat her Breast Cancer for 2 years. She goes to the pharmacy to fill her next month’s supply, and is given a bottle with a different name on the label. My office gets a frantic phone call that they gave her the wrong drug. Several phone calls later, we are able to assure her that the new refill contains a generic compound that is identical to the brand name drug she has been taking. Switching to the generic will not affect the efficacy, and will save her money.
Where are the low cost treatments?
What causes blood to clot? And what prevents blood from clotting?
What causes blood to clot? And what prevents blood from clotting?
The Yin and the Yang of the blood clotting system: We need blood to clot at points of injury, to plug up the hole and prevent us from bleeding uncontrollably. And we need the clot to be localized to the point of injury and not propagate through our blood vessels, bringing circulation to a halt, like a bad traffic jam. These two systems are in fine balance, keeping each other in control.
What are neutraceuticals? And what are pharmaceuticals?
What are neutraceuticals, and what are pharmaceuticals?
Through the ages, different cultures found medicinal properties in foods that were available to them. These would include spices like turmeric, which would then be used in poultices for their anti-inflammatory and anti bacterial properties for wound care. These then evolved into tinctures and extracts of different herbs, roots and barks in old world medical systems, e.g. Ayurvedic systems, as well as those used by native healers.
How do clinical trials get funded?
How do clinical trials get funded?
Clinical trials are expensive. Even when the primary research on the drug development has been, animal studies have been completed for the possibility of response, human trials need to be conducted for safety and efficacy. This requires millions of dollars to deliver the treatments and to gather the data and analyze it over the length of the trial and beyond.
What is lymphedema?
What is lymphedema?
As blood flows through our arteries supplying essential oxygen and nutrients throughout the body, it flows through smaller and smaller channels, and finally bathing the cells in the tissue fluid. This tissue fluid returns to the larger circulatory system by the venous system and lymphatics. If the architecture of the lymphatics is disrupted, the flow of tissue fluid back is hampered. This leads to a back up in the end organ causing swelling.
What do Cancer Statistics Tell us?
What is neuropathy?
What is neuropathy?
Motor nerves carry commands from the central command center (the brain and spinal cord) to the end point, the muscles that carry out the commands: the muscles of our arms and legs, muscles in our face, and throat.
Sensory nerves carry sensation back to the command center, and carry the sensation of hot and cold, and pain. When there is damage to the sensory nerves, this changes the level of sensation. Sometimes, this causes numbness; other times, pain.
How to find your balance?
Finding your balance:
Dealing with a cancer diagnosis or any other chronic illness starts an internal tug of war for both patients and family members. There is a balance between acknowledging the difficulty of facing a life changing diagnosis, the sorrow, the anger and the frustration, with the strength needed to get through gathering and processing the information.
Why do Genetic Testing?
What is a Gene mutation? We have 23 (22 autosomal pairs of genes + 1 X/Y pair), and carry 2 copies of each gene, one inherited from each parent, for each pair. Genes determine form and function, and each characteristic can require 2 functional genes, or only one. When one faulty copy is enough to cause a disease, that is a dominant mutation. When both copies are needed to be faulty to cause a disease, it is a recessive mutation. With dominant inherited mutations, the pathway to cancer if faster. If there is no inherited gene mutation, such changes have to occur by chance.
When we take a history from a newly diagnosed patient, we ask for a family tree of Cancer Diagnoses. Often, we get an answer that “Cancer runs in my family”. In that case, we do try to map out a family tree, marking who got what kind of cancer, and at what age, and what the outcome was. Certain patterns can emerge, like early age of diagnosis, multiple cancers within the same person, the same cancers in most 1st degree relatives. These point to inherited genetic abnormalities. E.g.
-BRCA 1 and 2 mutations, which confer an increased risk of ovarian and/ or breast cancer.
-Lynch syndrome, which is caused by a dominant mutation in DNA mismatch repair genes, which causes an increased incidence mainly of colon and uterus cancers.
-Li-Fraumeni syndrome with a dominant mutation in p53 (a tumor suppressor gene on chromosome 17). One bad copy inherited from a parent causes high rates of early breast cancer, sarcoma, brain and adrenal gland cancers.
Why test? The decision to test should be made after a thoughtful discussion regarding the ramifications of such testing. The US law now protects against discrimination in the event that you test positive for a cancer causing mutation. The knowledge that family members who do not yet have the disease, but carry the mutation can enable them to decide to undertake preventive surgery, e.g. removal and reconstruction of breasts, removal of ovaries, regular screening colonoscopy at an earlier age, etc.
Often, even if cancer runs in your family, we have not yet identified the gene mutation that may predispose to that cancer, and cannot detect it.
Non genetic reasons can also cause cancer to cluster in families: where we live, the occupations we pursue, the foods we eat, and whether we exercise, smoke or drink alcohol in excess. We do not have much control over some of these factors. We live and grow up where we do, and pursue occupations that are available to us. But we can work at improving our environmental conditions by decreasing pollution. We can improve our personal habits by not smoking, and exercising and eating and drinking in moderation. These changes have a direct and measurable impact on our cancer risk, independent of genetic mutations.
The other kind of genetic mutation testing takes place after cancer diagnosis. The DNA of the cancer cell is tested for specific mutations that have drugs designed to work against them. These drugs attack only the intended target, and have minimal impact on the rest of the body’s cells, sparing patients the toxicity of chemotherapy. However, they only work against the targeted mutation, and would not be effective without it. This way of treating cancer is gaining ground with more targets for more designer drugs being developed. In the coming decades, our current way of choosing chemotherapy may seem very primitive.
What is Multiple Myeloma?
What is Multiple Myeloma?
MM is a malignancy of plasma cells which live in the Bone Marrow. They are an important part of the Immune system, and manufacture infection-fighting proteins called Immunoglobulins. When plasma cells become malignant, they grow excessively, creating local and systemic problems. Since they are present in the bone marrow, they occupy the marrow throughout the body. This occupation crowds out normal cells, causing anemia, low platelet counts and decreases the number of normal white cells, thus decreasing the ability to fight infection. As the condition worsens and grows, it can dissolve the surrounding bone, and weaken it, causing fractures. As the bone dissolves, the blood calcium levels rises to abnormal levels.
What is DNR?
What is DNR?
Do not Resuscitate is a directive made by the patient, giving instructions to the extent of treatment that should be attempted, in case their heart or lungs should fail. This decision is best made in advance, in the absence of a crisis. It usually involves a dialogue between the patient, the family and the physician.